Clinical outcomes of anti‐reflux mucosal ablation for gastroesophageal reflux disease: An international bi‐institutional study

Overview of attention for article published in Journal of Gastroenterology & Hepatology, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

A number of patients undergoing the endoscopic treatment may experience significant reductions in GERD symptoms.

Antireflux mucosal ablation (ARMA) cuts short-term gastroesophageal reflux disease (GERD) symptoms in two-thirds of patients…

Antireflux mucosal ablation (ARMA) cuts short-term gastroesophageal reflux disease (GERD) symptoms in two-thirds of patients…

MONDAY, Nov. 6, 2023 -- Antireflux mucosal ablation (ARMA) cuts short-term gastroesophageal reflux disease (GERD) symptoms in…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.